Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 35 resultados

T-RAFIC: Training network for tracking and controlling therapeutic immune cells in cancer Cancer immunotherapies have been established in a growing number of clinical indications and the pace of development is massively accelerat...
2024-07-16 - 2029-03-31 | Financiado

ISIDORe: Integrated Services for Infectious Disease Outbreak Research FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-02 The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado

BRCA INSIGHTS: Understanding the functions of the BRCA protein complexes in DNA break repair and in replication str... FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA tramitó un H2020: ERC-2020-ADG BRCA1, BRCA2 and associated factors are frequently mutated in familial and sporadic cancers of the breast and ovary. The BRCA proteins have...
2021-06-03 - 2027-03-31 | Financiado

ATAC: Antibody therapy against coronavirus COVID 19 FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020 ATAC aims at developing passive immunotherapy against COVID-19. Human antibodies will be obtained from blood of CoV-recovered donors from Ch...
2020-04-06 - 2023-07-31 | Financiado

TIL-FIT: Increasing the fitness of tumor infiltrating T cells for cellular immunotherapy FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA tramitó un H2020: ERC-2018-STG Adoptive T cell therapies (ACTs) are emerging as a promising strategy to treat cancer. Tumor-infiltrating lymphocytes (TILs) are expanded ex...
2018-12-12 - 2023-12-31 | Financiado

RTCure: Rheuma Tolerance for Cure FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA participó en un H2020: H2020-JTI-IMI2-2016-09-two-stage In line with IMI2 goals for improved therapies and precision medicine, the aim of this proposal is to prevent and treat RA or its progressio...
2017-08-25 - 2023-08-31 | Financiado

TANTUMorNEUVACCINE: Neutrophil subtypes distinct cellular targets for therapeutic intervention FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA tramitó un H2020: H2020-MSCA-IF-2016 In cancer immunotherapy and vaccine field, considerable efforts have been invested to optimize the induction of effector T cells that, by re...
2017-04-04 - 2020-09-30 | Financiado

ZIKAlliance: A global alliance for Zika virus control and prevention FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA participó en un H2020: H2020-SC1-2016-2017 "ZIKAlliance is a multidisciplinary project with a global ""One Health"" approach, built: on a multi-centric network of clinical cohorts in...
2016-12-13 - 2021-09-30 | Financiado

HRMECH: Nucleases in homologous recombination from basic principles to genome editing FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA tramitó un H2020: ERC-2015-CoG Homologous recombination plays a crucial role to repair DNA strand breaks that may occur spontaneously upon replication fork collapse, durin...
2016-08-08 - 2022-03-31 | Financiado

EHVA: European HIV Vaccine Alliance EHVA a EU platform for the discovery and evaluation of novel prophy... FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA participó en un H2020: H2020-PHC-2014-2015 Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. T...
2015-12-17 - 2023-12-31 | Financiado

BROADimmune: Structural genetic and functional analyses of broadly neutralizing antibodies against human pathoge... FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA tramitó un H2020: ERC-2014-ADG The overall goal of this project is to understand the molecular mechanisms that lead to the generation of potent and broadly neutralizing an...
2015-09-30 - 2020-09-30 | Financiado

ABIRISK: Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the ri... FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA participó en un FP6: The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique pane...
2012-03-01 - 2018-02-28 | Financiado

LINFOEPAB: CD4 T AND B LYMPHOCYTES IN HEPATITIS B PATIENTS ROLE IN ACUTE AND CHRONIC INFECTION FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA tramitó un FP7: "Hepatitis B virus (HBV), an hepatotropic non-cytopathic DNA virus, still represents a global health problem, with million of deaths for yea...
Financiado

IRINVAC: IMMUNE RESPONSES TO INFLUENZA VACCINE FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA tramitó un FP7: Influenza virus continues to represent a major global health problem and the recent pandemic caused by a H1N1 strain of influenza A (swine f...
Financiado

MD-THIV: Migration and Differentiation of Th17 Cells in HIV SIV Infection FONDAZIONE PER LISTITUTO DI RICERCA IN BIOMEDICINA tramitó un FP7: More than 25 years after the discovery of human immunodeficiency virus (HIV) as the causative agent of AIDS, the mechanisms governing pathog...
Financiado

IRB